Blade Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Blade Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11095
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company that develops novel anti-fibrotic therapies to treat various fibrotic disorders. The company’s lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across diverse indications. Its Blade conducts research and development programs to discover new drugs that modulate fibrosis-related diseases such as diabetic nephropathy (DN), idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH). Blade Therapeutics offers services such as primary sclerosing cholangitis (PSC), systemic sclerosis (SSc), corneal fibrosis, and others. The company works in partnership with Scleroderma Research Foundation (SRF) to treat disorders of fibrosis, including scleroderma. Blade Therapeutics is headquartered in South San Francisco, California, the US.

Blade Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blade Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Blade Therapeutics Raises Additional USD18.3 Million in Series B Financing 10
Blade Therapeutics Raises USD27 Million in Series B Financing 12
Blade Therapeutics Raises USD6.5 Million in Series A Financing 14
Blade Therapeutics Raises Funds in Venture Financing 15
Licensing Agreements 16
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 16
Blade Therapeutics Inc – Key Competitors 17
Blade Therapeutics Inc – Key Employees 18
Blade Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Feb 27, 2018: Blade Therapeutics Appoints Ryan Maynard As Chief Financial Officer 20
Jun 20, 2017: Blade Therapeutics Expands Leadership Team as Company Advances R&D Pipeline Addressing Fibrotic Diseases 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blade Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blade Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blade Therapeutics Raises Additional USD18.3 Million in Series B Financing 10
Blade Therapeutics Raises USD27 Million in Series B Financing 12
Blade Therapeutics Raises USD6.5 Million in Series A Financing 14
Blade Therapeutics Raises Funds in Venture Financing 15
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 16
Blade Therapeutics Inc, Key Competitors 17
Blade Therapeutics Inc, Key Employees 18

List of Figures
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Blade Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Blade Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avacta Group Plc (AVCT):企業の製品パイプライン分析2018
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Tata Consultancy Services Limited:企業の戦略・SWOT・財務情報
    Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Consultancy Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Orchid Orthopedic Solutions LLC-医療機器分野:企業M&A・提携分析
    Summary Orchid Orthopedic Solutions LLC (Orchid Orthopedic) is a medical device company that offers orthopedic and medical device contract design, and manufacturing outsourcing services. The company provides proprietary solutions such as medical device design and development, implant bone in-growth …
  • Dentsply Sirona, Inc.:戦略・SWOT・企業財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Revera Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revera Inc (Revera), formerly Retirement Residences Real Estate Investment Trust, is a healthcare service provider that offers assisted living, independent living, seniors’ apartments,memory care and long term care services. The center provides person-centered care, quality care, clinical pr …
  • AZTherapies Inc-製薬・医療分野:企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Contact Energy Ltd (CEN):企業の財務・戦略的SWOT分析
    Contact Energy Ltd (CEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Chiesi USA Inc:企業の戦略的SWOT分析
    Chiesi USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Illumina, Inc.:企業のM&A・事業提携・投資動向
    Illumina, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illumina, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • TissueGen Inc:企業の製品パイプライン分析2018
    Summary TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. Tis …
  • Mitochon Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotech company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products comprise mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stroke, h …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bio Techne Corp (TECH)-製薬・医療分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • SGS SA (SGSN):医療機器:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Milliken & Company:企業の戦略・SWOT・財務情報
    Milliken & Company - Strategy, SWOT and Corporate Finance Report Summary Milliken & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆